Search - tctmd.com

Displaying 661 - 680 of 1180

Sort: Relevancy | Date

News Daily News

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Michael O'Riordan

April 02, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Daily News

‘Gaming’ the AUC for Revascularization? Study Suggests Not

Michael O'Riordan

March 25, 2021

News Daily News

FDA Approves Rilonacept to Treat Recurrent Pericarditis and to Curb Recurrences

Shelley Wood

March 25, 2021

News Daily News

COVID-19: TCTMD’s Daily Dispatch for March Week 4

Shelley Wood

March 22, 2021

News Daily News

INSPIRATION: No Dip in COVID-19 Deaths or Thromboses With Higher Anticoagulation Dose

L.A. McKeown

March 19, 2021

News Daily News

Experts Fear Coronary CT Advice for Patients Misses the Mark

Michael O'Riordan

March 19, 2021

News Daily News

Little Improvement Seen Over Two Decades in US Racial Health Disparities

L.A. McKeown

March 15, 2021

News Daily News

MI Hospitalizations Down 20% at COVID-19 Peak in Italy, With a Heavy Cost

Michael O'Riordan

March 04, 2021

News Daily News

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

Michael O'Riordan

March 03, 2021

News Daily News

No Harm, No Help With Bioabsorbable-Polymer Stents: Registry

Michael O'Riordan

March 01, 2021

News Opinion CV Team Dispatch

March 2021 News Roundup

L.A. McKeown

March 01, 2021

News Daily News

Potent Antiplatelets Pre-CABG for ACS? Meta-analysis Stirs Debate

L.A. McKeown

February 26, 2021

News Daily News

CV Complications of Malaria Rare but Portend Poor Prognosis

Michael O'Riordan

February 22, 2021

News Daily News

COVID-19: TCTMD’s Daily Dispatch for February Week 4

Todd Neale

February 22, 2021

News Daily News

Smoking, Drinking, and Drugs—All Signs Point to Earlier ASCVD

Michael O'Riordan

February 19, 2021

News Daily News

New FDA Indication Opens Up Use of Sacubitril/Valsartan in HFpEF

Todd Neale

February 16, 2021

News Daily News

Site Investigators Missed Clinical Events in GLOBAL LEADERS

Michael O'Riordan

February 12, 2021

News Daily News

FDA Approves Evinacumab for Rare Homozygous FH

Michael O'Riordan

February 11, 2021

News Features

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

Todd Neale

February 08, 2021

Advertisement

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Roughly 80% of ESC Guideline Writers Have Financial COIs

‘Gaming’ the AUC for Revascularization? Study Suggests Not

FDA Approves Rilonacept to Treat Recurrent Pericarditis and to Curb Recurrences

COVID-19: TCTMD’s Daily Dispatch for March Week 4

INSPIRATION: No Dip in COVID-19 Deaths or Thromboses With Higher Anticoagulation Dose

Experts Fear Coronary CT Advice for Patients Misses the Mark

Little Improvement Seen Over Two Decades in US Racial Health Disparities

MI Hospitalizations Down 20% at COVID-19 Peak in Italy, With a Heavy Cost

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

No Harm, No Help With Bioabsorbable-Polymer Stents: Registry

March 2021 News Roundup

Potent Antiplatelets Pre-CABG for ACS? Meta-analysis Stirs Debate

CV Complications of Malaria Rare but Portend Poor Prognosis

COVID-19: TCTMD’s Daily Dispatch for February Week 4

Smoking, Drinking, and Drugs—All Signs Point to Earlier ASCVD

New FDA Indication Opens Up Use of Sacubitril/Valsartan in HFpEF

Site Investigators Missed Clinical Events in GLOBAL LEADERS

FDA Approves Evinacumab for Rare Homozygous FH

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content